The Maharashtra Food and Drug Administration (FDA) has escalated its statewide regulatory enforcement by issuing formal show-cause notices to leading Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff. The notices focus on their promotional appearances as brand endorsers in high-profile advertisements for Vimal Elaichi.

According to the state food safety regulator, the promotional campaign appears to create a direct brand association with Vimal Pan Masala—a product currently prohibited for manufacture, storage, distribution, and sale across Maharashtra. The authority alleges that marketing cardamom seeds under an identical umbrella brand name and visual identity may amount to indirect or surrogate advertising for a banned tobacco-related substance.

The regulatory move highlights the expanding scope of celebrity accountability under Indian consumer and food safety laws, reigniting widespread debate surrounding the legal boundaries of surrogate marketing.

Why Did Maharashtra FDA Issue Notices to the Three Actors?

The show-cause notices, issued by the FDA’s Greater Mumbai division, follow an official review of promotional campaigns broadcast across national television networks, satellite channels, and digital streaming platforms.

Under the leadership of Food Safety Commissioner Tukaram Mundhe, the department noted that all three actors featured prominently in the campaign. The FDA outlined several legal and procedural grounds for initiating regulatory scrutiny:

  • Direct Brand Association: The regulator stated that within Maharashtra, the name "Vimal" is overwhelmingly associated in public perception with pan masala rather than mouth fresheners or spices.
  • Potential to Mislead Consumers: The FDA noted that the visual presentation, signature taglines, distinctive packaging, and dialogue delivery could mislead the public by keeping a prohibited product brand prominent in the consumer consciousness.
  • Statutory Violations Invoked: The regulator cited Section 24 of the Food Safety and Standards Act (FSSA), 2006, which prohibits deceptive and misleading food advertisements, and referenced Section 53, which penalizes parties involved in publishing misleading promotional material.
  • Advertising Claim Standards: The notices also invoke the Food Safety and Standards (Advertising and Claims) Regulations, 2018, requiring all commercial claims to be unambiguous, verifiable, and free of deception.

What Is the Vimal Elaichi Advertisement Controversy?

The controversy surrounding flavoured cardamom (elaichi) commercials by pan masala manufacturers centers on the concept of umbrella branding.

While the commercials explicitly state they are marketing silver-coated cardamom seeds, health advocates, public interest litigators, and regulatory authorities argue that these campaigns function primarily to bypass advertising bans. The packaging dimensions, font typography, color scheme, and celebrity gestures mirror the manufacturer's core pan masala line.

The Maharashtra FDA has indicated that it is examining whether Vimal Elaichi is an independent commercial product with substantial market distribution or whether the campaign serves as a brand-extension mechanism designed to preserve recall for restricted chewable tobacco products.

Why Is Vimal Pan Masala Prohibited in Maharashtra?

Maharashtra originally prohibited the manufacture, storage, transportation, distribution, and sale of gutkha and pan masala containing tobacco, nicotine, or areca nut in 2012 under Section 30(2)(a) of the FSS Act, 2006.

Because state-level prohibitions must be renewed on an annual basis, the Maharashtra Food Safety Commissioner issued a fresh statutory order in July, reinforcing the complete ban on specified chewable tobacco and areca-nut formulations for an additional 12 months.

Given this strict ban, the regulator maintains that any marketing campaign—direct or indirect—that promotes brand recall for prohibited pan masala compromises public health objectives.

What Is Surrogate Advertising?

Surrogate advertising occurs when a company promotes an unbanned or innocuous item (such as packaged mineral water, club soda, or cardamom seeds) using the identical brand name, logo, color palette, and visual styling of a prohibited product (such as alcohol, cigarettes, or pan masala).

Because direct advertising for tobacco and alcohol is banned across broadcast media under the Cigarettes and Other Tobacco Products Act (COTPA), 2003 and the Cable Television Networks (Regulation) Act, 1995, manufacturers create brand extensions to maintain visual prominence.

Both the Central Consumer Protection Authority (CCPA) and the Advertising Standards Council of India (ASCI) enforce strict criteria for brand extensions. To be legally recognized, an advertiser must demonstrate that the secondary product is produced in substantial volume, maintains independent retail distribution, and posts measurable sales separate from the restricted primary brand.

What Has the FDA Asked the Actors to Do?

The Maharashtra FDA’s notice outlines explicit directives, requiring Shah Rukh Khan, Ajay Devgn, and Tiger Shroff to respond within a 15-day compliance window:

  • Discontinue Promotional Work: Immediately cease active participation in and promotion of the Vimal Pan Masala / Elaichi campaign.
  • Remove Digital Materials: Delete related promotional clips, posters, and endorsements from personal social media accounts, video channels, and official websites.
  • Submit Commercial Contracts: Furnish copies of endorsement agreements, campaign briefs, remuneration details, and correspondence with the brand owner and advertising agencies.
  • Provide Due Diligence Evidence: Submit documented records of the background checks and regulatory verifications conducted before agreeing to the endorsement.
  • Prove Product Independence: Provide evidence demonstrating whether Vimal Elaichi exists as an independent, widely sold consumer item or serves as a surrogate vehicle.

Why Are Celebrity Endorsements Under Scrutiny?

Under Section 21 of the Consumer Protection Act, 2019, brand endorsers face direct legal liability for participating in misleading commercial advertisements. If celebrities fail to show they conducted proper due diligence regarding product claims, the CCPA can issue substantial penalties:

  • Financial Fines: Monetary penalties of up to ₹10 lakh for a first violation, rising to ₹50 lakh for subsequent contraventions.
  • Endorsement Bans: Authorities can prohibit an endorser from promoting any product or service for up to one year, extending to three years for repeat violations.
  • Food Safety Penalties: Under Section 53 of the FSS Act, individuals party to the publication of misleading food advertisements face fines of up to ₹10 lakh.

Because public figures wield significant influence over consumer behavior, regulators are holding brand ambassadors accountable to ensure their commercial work aligns with public health protections.

What Happens After the 15-Day Response Period?

The actors have 15 days to submit written explanations and supporting documentation, or request a personal hearing through legal representatives.

If the responses verify that comprehensive due diligence was conducted and no statutory provisions were violated, the regulator may conclude the inquiry or narrow its proceedings to the brand owner.

However, if the actors fail to respond within the deadline or if their explanations are found unsatisfactory, the FDA has warned it may initiate legal proceedings under the FSS Act and refer the matter to the CCPA and the Food Safety and Standards Authority of India (FSSAI) for further action.

Key Takeaways

  • Show-Cause Notices Issued: Maharashtra FDA has sent notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their Vimal Elaichi ad campaign.
  • Surrogate Advertising Allegation: The regulator alleges the campaign creates an association with banned Vimal Pan Masala.
  • 15-Day Deadline: The actors must respond within 15 days, provide due diligence records, and remove related content from digital platforms.
  • Endorser Liability: The case tests provisions of the Consumer Protection Act, 2019, and the Food Safety and Standards Act, 2006.

Conclusion

The Maharashtra FDA’s show-cause notices highlight the growing conflict between celebrity-led commercial branding and statutory public health mandates. While brands and endorsers have long maintained that cardamom seeds represent a permissible product category, state regulators are increasingly treating surrogate advertising as a direct circumvention of pan masala bans. As the 15-day response window unfolds, the outcome of this case is poised to set an important legal precedent for celebrity endorsement contracts, brand extensions, and surrogate marketing regulations across India.